Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Core decompression with PLGA-loaded deferoxamine for early osteonecrosis of the femoral head
IRCT20161121031003N3Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of deferoxamine in osteonecrosis of the hip (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Femoral head necrosis rate. Started Jan 2019; status: completed.
02
Drugs
deferoxamine
03
Conditions
osteonecrosis of the hip
Beyond the preview
Go deeper on IRCT20161121031003N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161121031003N3.